Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02727699
Brief Title: A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) (XanADu)

First Submitted : March 21, 2016
First Submitted that Met QC Criteria : March 30, 2016
First Posted : April 5, 2016 (Estimate)

Results First Submitted : September 15, 2020
Results First Submitted that Met QC Criteria : April 13, 2021
Results First Posted : May 6, 2021

Last Update Submitted that Met QC Criteria : April 13, 2021
Last Update Posted : May 6, 2021